Lawrence Pfeffer

Affiliations: 
University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Pathology, Cell Biology, Molecular Biology
Google:
"Lawrence Pfeffer"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Zhao G, Zhao X, Liu Z, et al. (2025) Knockout or inhibition of DHPS suppresses ovarian tumor growth and metastasis by attenuating the TGFβ pathway. Scientific Reports. 15: 917
Asemota S, Effah W, Holt J, et al. (2024) A molecular switch from tumor suppressor to oncogene in ER+ve breast cancer: Role of androgen receptor, JAK-STAT, and lineage plasticity. Proceedings of the National Academy of Sciences of the United States of America. 121: e2406837121
Johnson DL, Kumar R, Kakhniashvili D, et al. (2024) Ccr4-Not ubiquitin ligase signaling regulates ribosomal protein homeostasis and inhibits 40S ribosomal autophagy. The Journal of Biological Chemistry. 107582
Johnson DL, Kumar R, Kakhniashvili D, et al. (2023) Ccr4-Not ubiquitin ligase signaling regulates ribosomal protein homeostasis and inhibits 40S ribosomal autophagy. Biorxiv : the Preprint Server For Biology
Laribee RN, Boucher AB, Madireddy S, et al. (2023) The STAT3-Regulated Autophagy Pathway in Glioblastoma. Pharmaceuticals (Basel, Switzerland). 16
Antonia RJ, Karelehto E, Toriguchi K, et al. (2022) STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20. Journal of Cellular and Molecular Medicine. 26: 4591-4601
Bhattacharya S, Yin J, Yang C, et al. (2022) STAT3 suppresses the AMPKα/ULK1-dependent induction of autophagy in glioblastoma cells. Journal of Cellular and Molecular Medicine
Wang Y, Yang C, Sims MM, et al. (2022) SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo. Cancer Letters. 533: 215614
He Y, Yang C, Wang Y, et al. (2021) Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells. Bioorganic & Medicinal Chemistry. 53: 116533
Yang C, Wang Y, Sims MM, et al. (2021) Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma. Pharmaceuticals (Basel, Switzerland). 14
See more...